Suppression of lymphokine-activated killer cell generation by tumor-infiltrating lymphocytes

This publication has 13 references indexed in Scilit:

• Til from renal‐cell carcinoma: Restimulation with tumor influences proliferation and cytolytic activity
  International Journal of Cancer, 1990
• Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma.
  The Journal of Experimental Medicine, 1989
• TUMOUR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2 IN TREATMENT OF ADVANCED CANCER
  The Lancet, 1989
• Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
  New England Journal of Medicine, 1988
• Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study.
  Journal of Clinical Oncology, 1988
• Anti-Tumor Reactivity of Human Lymphokine Activated Killer (LAK) Cells Against Fresh and Cultured Preparations of Renal Cell Cancer
  Journal of Urology, 1988
• Inhibition of Endothelial Regeneration by Type-Beta Transforming Growth Factor from Platelets
  Science, 1986
• Functional characterization of T lymphocytes propagated from human lung carcinomas
  Clinical Immunology and Immunopathology, 1986
• In vitro cytotoxicity and transplantation protection by autologous natural and activated killer cells against an in vitro transformed tumorigenic fibroblast line. A case study.
  Journal of Clinical Investigation, 1985
• Activated T lymphocytes within human solid tumors
  Cancer Immunology, Immunotherapy, 1979